SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 242 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $200,440 | -46.4% | 6,668 | -48.4% | 0.01% | -36.4% |
| Q2 2022 | $374,000 | -17.4% | 12,919 | -8.0% | 0.01% | -8.3% |
| Q1 2022 | $453,000 | +4.4% | 14,037 | -5.6% | 0.01% | +9.1% |
| Q4 2021 | $434,000 | +71.5% | 14,877 | +56.5% | 0.01% | +37.5% |
| Q3 2021 | $253,000 | -46.3% | 9,504 | -37.8% | 0.01% | -42.9% |
| Q2 2021 | $471,000 | +81.2% | 15,283 | +53.9% | 0.01% | +55.6% |
| Q1 2021 | $260,000 | -2.3% | 9,932 | -5.9% | 0.01% | -18.2% |
| Q4 2020 | $266,000 | +17.7% | 10,553 | -2.7% | 0.01% | 0.0% |
| Q3 2020 | $226,000 | -69.6% | 10,848 | -79.5% | 0.01% | -89.3% |
| Q3 2015 | $743,000 | – | 52,952 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |